Institutional Review Board (IRB) Research Center (RCENCI) Overview Background and History of IRB at NCI-Egypt Members Federalwide Assurance Meeting Calendar GCP Certification Policies and Procedures Applications Submission Forms Useful videos Protocols for MD thesis Protocols for MSc thesis Protocols for other trials/studies Documents to be presented for amendments Documents to be presented on six (6) months basis Documents to be presented for renewal approval Documents to be presented for termination approval Documents presented promptly Mission RCENCI Services Research at ENCI Publications of ENCI staff Important documents and Templates RCENCI position in the ENCI organizational Chart Key constituents of the RCENCI RCENCI Administration RCENCI activities and workshops Research Plan Good Clinical Practice (GCP) Keys to build a successful research team and site Background and History of IRB at NCI-Egypt IRB of the Egyptian National Cancer Institute was established in 1997. It was composed of 5 members including both genders, non-affiliated and non-medical members. The load of review was small and was mostly pharmaceutically sponsored studies. Later the local researchers of the National Cancer institute subjected their proposals for review and approval. The IRB also reviews research studies from other educational centres that lacking this service. In 2004, the NCI IRB signatory official got registered at US Department of Health & Human Services (Organization No. IORG0003381, IRB No. IRB00004025, Federal Wide Assurance (FWA) No. FWA00007284. The number of submitted research studies increased progressively through the years and members of the IRB also increased to cope with the increased work load. In 2009, the Vice Dean of the NCI issued an Act that mandates IRB approval for all MSc and MD thesis.